Association between antithrombotic drug use before chronic subdural haematoma and outcome after drainage: a systematic review and meta-analysis.

Neurosurg Rev 2018 Apr 26;41(2):439-445. Epub 2017 May 26.

Centre for Clinical Brain Sciences, University of Edinburgh, Chancellor's Building, 49 Little France Crescent, Edinburgh, EH16 4SB, Midlothian, UK.

In view of their age and vascular co-morbidities, people are often taking an antithrombotic drug when diagnosed with chronic subdural haematoma (CSDH). It is unclear whether antithrombotic use at CSDH diagnosis, or resumption afterwards, is associated with recurrent CSDH or vaso-occlusive events. We systematically reviewed the literature for studies reporting CSDH recurrence or vaso-occlusive events after drainage of CSDH associated with antithrombotic drug use. We searched Medline 1946-2016 and Embase 1974-2016 inclusive for cohort studies reporting the risk of CSDH recurrence or vaso-occlusive events after CSDH associated with antithrombotic (anticoagulant or antiplatelet) drug use. We meta-analysed outcome data using a random effect model and assessed inconsistency between studies using the I-squared (I ) statistic. We found 20 studies reporting outcome after drainage of CSDH associated with antithrombotic drug use. Before CSDH drainage, 337 (11.5%) of 2941 patients in 12 studies used an anticoagulant drug and 600 (19%) of 3150 patients in 11 studies used an antiplatelet drug. The association between antithrombotic drug use and CSDH recurrence was significant for antiplatelet drug use (relative risk [RR] 1.36, 95% CI 1.05 to 1.75; I  = 36.3%), but marginally significant for anticoagulant drug use (RR 1.38 95% CI 1.00-1.91; I  = 37.5%). Two studies including 30 patients reported one vaso-occlusive outcome event after CSDH. Antithrombotic drug use at CSDH diagnosis may be associated with post-operative CSDH recurrence. It is unclear whether this is attributable to confounding factors, antithrombotic reversal strategies or antithrombotic drug resumption. Further observational studies and randomised controlled trials of antithrombotic drug resumption are needed.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10143-017-0860-xDOI Listing
April 2018
49 Reads

Publication Analysis

Top Keywords

antithrombotic drug
32
csdh recurrence
16
drug
13
studies reporting
12
associated antithrombotic
12
csdh associated
12
antiplatelet drug
12
csdh
12
vaso-occlusive events
12
drug csdh
12
antithrombotic
10
csdh diagnosis
8
drainage csdh
8
patients studies
8
drug resumption
8
studies
8
anticoagulant drug
8
recurrence vaso-occlusive
8
chronic subdural
8
outcome drainage
8

References

(Supplied by CrossRef)

H Baechli et al.
Neurosurg Rev 2004

D Gaist et al.
JAMA 2017

LB Miranda et al.
J Neurosurg 2011

A Chari et al.
Br J Neurosurg 2014

R Weigel et al.
J Neurol Neurosurg Psychiatry 2003

OP Aspegren et al.
Clin Neurol Neurosurg 2013

A Baraniskin et al.
J Neurol Surg 2014

K-H Chon et al.
Acta Neurochir 2012

MT Forster et al.
J Clin Neurosci 2010

V Gonugunta et al.
Br J Neurosurg 2001

T Kawamata et al.
Surg Neurol 1995

Similar Publications